Celgene (CELG) PT Raised to $175 at Oppenheimer
Tweet Send to a Friend
Oppenheimer analyst Leah Rush Cann raised her price target on Celgene (NASDAQ: CELG) to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE